FREDI, MICAELA
 Distribuzione geografica
Continente #
NA - Nord America 6.889
AS - Asia 3.336
EU - Europa 2.349
SA - Sud America 677
AF - Africa 100
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 13.365
Nazione #
US - Stati Uniti d'America 6.752
SG - Singapore 1.256
CN - Cina 931
BR - Brasile 572
IT - Italia 426
DE - Germania 421
HK - Hong Kong 405
UA - Ucraina 374
VN - Vietnam 264
FI - Finlandia 195
FR - Francia 190
GB - Regno Unito 184
RU - Federazione Russa 149
TR - Turchia 128
IE - Irlanda 108
IN - India 84
PL - Polonia 80
CA - Canada 68
BD - Bangladesh 56
SE - Svezia 46
MX - Messico 45
AR - Argentina 42
ZA - Sudafrica 36
IQ - Iraq 33
PK - Pakistan 28
ES - Italia 23
NL - Olanda 23
AT - Austria 22
ID - Indonesia 21
JP - Giappone 18
MA - Marocco 17
EC - Ecuador 15
BE - Belgio 14
CZ - Repubblica Ceca 14
LT - Lituania 14
SA - Arabia Saudita 14
KE - Kenya 11
PY - Paraguay 11
VE - Venezuela 10
AE - Emirati Arabi Uniti 9
AL - Albania 9
AU - Australia 9
IL - Israele 9
PH - Filippine 9
UZ - Uzbekistan 9
CO - Colombia 8
KZ - Kazakistan 8
NG - Nigeria 8
MK - Macedonia 7
PT - Portogallo 7
AZ - Azerbaigian 6
DZ - Algeria 6
ET - Etiopia 6
NP - Nepal 6
CL - Cile 5
EG - Egitto 5
GR - Grecia 5
HN - Honduras 5
JO - Giordania 5
MY - Malesia 5
RS - Serbia 5
KR - Corea 4
LV - Lettonia 4
NO - Norvegia 4
PE - Perù 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BH - Bahrain 3
BO - Bolivia 3
CH - Svizzera 3
EU - Europa 3
JM - Giamaica 3
LB - Libano 3
NI - Nicaragua 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
AO - Angola 2
BY - Bielorussia 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
LU - Lussemburgo 2
LY - Libia 2
OM - Oman 2
PA - Panama 2
TN - Tunisia 2
AM - Armenia 1
BB - Barbados 1
CY - Cipro 1
FK - Isole Falkland (Malvinas) 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
Totale 13.348
Città #
Fairfield 717
Singapore 693
Ashburn 635
Woodbridge 481
Hong Kong 403
San Jose 326
Houston 303
Jacksonville 287
The Dalles 270
Cambridge 266
Seattle 238
Beijing 234
Wilmington 231
Chandler 219
Ann Arbor 213
Chicago 194
Los Angeles 191
New York 181
Princeton 173
Helsinki 143
Dublin 108
Lauterbourg 108
Istanbul 104
Dallas 93
Ho Chi Minh City 82
Salt Lake City 81
Munich 76
Warsaw 76
Nanjing 69
Brescia 65
Hanoi 60
Council Bluffs 48
Moscow 48
São Paulo 47
Buffalo 46
Shanghai 46
Redondo Beach 45
San Francisco 45
London 37
San Diego 36
Des Moines 34
Nanchang 32
Nuremberg 32
Elk Grove Village 31
Milan 29
Orem 29
Tampa 29
Turku 28
Lancaster 27
Santa Clara 27
Changsha 25
Shenyang 25
Johannesburg 24
Montreal 24
Phoenix 24
Brooklyn 23
Chennai 22
Hebei 22
Tianjin 20
Atlanta 18
Romola 18
Tokyo 18
Jiaxing 16
Mexico City 16
Rome 16
Denver 15
Frankfurt am Main 15
Brussels 14
Miami 14
Manchester 13
Porto Alegre 13
Cagliari 12
Dong Ket 12
Jinan 12
Rio de Janeiro 12
Stockholm 12
Belo Horizonte 11
Brasília 11
Da Nang 11
Haiphong 11
Ottawa 11
Sterling 11
Vienna 11
Amsterdam 10
Biên Hòa 10
Dearborn 10
Dhaka 10
Dulles 10
Hangzhou 10
Nürnberg 10
Rozzano 10
Toronto 10
Washington 10
Baghdad 9
Bergamo 9
Campinas 9
Falkenstein 9
Guangzhou 9
Lahore 9
Ningbo 9
Totale 8.711
Nome #
Frequency Evaluation of the Interleukin-6 −174G>C Polymorphism and Homeostatic Iron Regulator (HFE) Mutations as Disease Modifiers in Patients Affected by Systemic Lupus Erythematosus and Rheumatoid Arthritis 699
Aicardi-Goutieres syndrome, a rare neurological disease in children: a new autoimmune disorder? 232
Sine causa tetraparesis: A pilot study on its possible relationship with interferon signature analysis and Aicardi Goutières syndrome related genes analysis 229
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 215
Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study 205
A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus 189
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 188
C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis 184
Macrophage activation syndrome in adult systemic lupus erythematosus: Report of seven adult cases from a single Italian rheumatology center 183
Prevalence and disease-specific risk factors for Lower Urinary Tract symptoms in Systemic Sclerosis: an international multi-centric study 179
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 178
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. 175
Systemic lupus erythematosus and endothelial dysfunction: A close relationship 174
Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept 173
Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. 172
Antiphospholipid antibodies mediate autoimmunity against dying cells. 167
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 167
Longterm outcome of patients with primary antiphospholipid syndrome: A retrospective multicenter study 166
Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years 162
Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome 160
Treatment and functional outcome of patients with cystoid macular edema: a single-center experience 155
The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre study 155
The clinico-serological spectrum of overlap myositis 154
Risk factors for adverse maternal and fetal outcomes in women with confirmed aPL positivity: Results from a multicenter study of 283 pregnancies 153
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis 150
Relationship between endothelial dysfunction, videocapillaroscopy and circulating CD3+CD31+CXCR4+ lymphocytes in systemic lupus erythematosus without cardiovascular risk factors 149
Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera 145
Systemic vasculitis and pregnancy: a multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies 142
Exploring Autoimmunity in a Cohort of Children with Genetically Confirmed Aicardi–Goutières Syndrome 141
Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onset 139
The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases 138
Rare autoantibodies to cellular antigens in systemic lupus erythematosus. 138
A prospective evaluation of endothelial dysfunction in Systemic Lupus Erythematosus patients without previous cardiovascular events: preliminary results. 137
A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies. 136
The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies. 136
Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis 135
IRF5 is associated with primary antiphospholipid syndrome,but is not a major risk factor 132
Anti-topoisomerase-I antibodies in systemic lupus erythematosus and potential association with the presence of anti-dsDNA antibodies 130
Systematic Review and Meta-analysis on the Association of Occupational Exposure to Free Crystalline Silica and Rheumatoid Arthritis 129
Clinical significance of IgA anti-cardiolipin and IgA anti-β2glycoprotein I antibodies. 127
Analysis of C9Orf72 Expansions in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: Preliminary Data 127
The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus 127
Belimumab decreases flare rate and hinders the expected damage progression in patients with active systemic lupus erythematosus 125
Disease course and obstetric outcomes of pregnancies in juvenile idiopathic arthritis: are there any differences among disease subtypes? A single-centre retrospective study of prospectively followed pregnancies in a dedicated pregnancy clinic 124
Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study 123
Myositis autoantibodies and clinical phenotypes 122
Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis 121
Letter to editor: New onset/recurrence of inflammatory arthralgia/spondyloarthritis in patients treated with vedolizumab for intestinal bowel disease 121
Evaluation of a large set of patients with Autoimmune Polyglandular Syndrome from a single reference centre in context of different classifications 117
Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies. 117
Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies 117
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting 115
Neutrophil Extracellular Traps (NETs) profiles in patients with incident SLE and lupus nephritis 114
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 111
RELATIONSHIP BETWEEN SLE SUSCEPTIBILITY GENES AND CLINICAL MANIFESTATIONS IN A COHORT OF PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME 110
ANTIPHOSPHOLIPID ANTIBODIES AND CEREBROVASCULAR EVENTS. WHICH FACTORS ASSOCIATE WITH ONSET AND RECURRENCE? - POSTER TOURS 107
Semiquantitative analysis of line blot assay for myositis-specific and myositis-associated antibodies: a better performance? 105
Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis 104
Autoimmune polyglandular syndrome type 4: experience from a single reference center 103
Aseptic meningitis occurring during anti-TNF-alpha therapy in rheumatoid arthritis and ankylosing spondylitis 103
Triple antiphospholipid (aPL) antibodies positivity is associated with pregnancy complications in aPL carriers: A multicenter study on 62 pregnancies 102
Should we treat congenital heart block with fluorinated corticosteroids? 101
Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment options 99
Systematic review and meta-analysis of epidemiological studies on the association of occupational exposure to free crystalline silica and systemic lupus erythematosus 98
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry 95
Managing puerperium in patients with systemic autoimmune diseases: an update 95
Inherited thrombophilia in women with poor aPL-related obstetric history: prevalence and outcomes. Survey of 208 cases from the European Registry on Obstetric Antiphospholipid Syndrome cohort 93
Use of rituximab in a multicentre cohort of patients with rheumatic diseases during the outbreak of novel SARS-COV-2 infection 92
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 91
Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohort. 90
Pregnancy in antiphospholipid syndrome: what should a rheumatologist know? 89
Reply to: Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis by Castellanos-Moreira et al 88
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 87
Anti-SSA/Ro positivity and congenital heart block: obstetric and foetal outcome in a cohort of anti-SSA/Ro positive pregnant patients with and without autoimmune diseases 86
Maternal, pregnancy and neonatal outcomes of twin gestations in women with rheumatic diseases: A single-center, case-control study 85
Comparison of Lineblot and Immunoprecipitation Methods in the Detection of Myositis-Specific and Myositis-Associated Antibodies in Patients with Idiopathic Inflammatory Myopathies: Consistency with Clinical Diagnoses 84
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence 83
Severe muscle damage with myofiber necrosis and macrophage infiltrates characterize anti-Mi2 positive dermatomyositis 83
Efficacy of COVID-19 mRNA vaccination in patients with autoimmune disorders: humoral and cellular immune response 83
Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies. 82
Gender differences in primary antiphospholipid syndrome with vascular manifestations in 433 patients from four European centres 81
The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus 80
Evaluation of the incidence of melanoma and non-melanoma skin cancer in patients with systemic lupus erythematosus and systemic sclerosis 78
Neutrophil Extracellular Traps in the Autoimmunity Context. 78
Second Wave Antibodies in Autoimmune Renal Diseases: The Case of Lupus Nephritis 78
Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis 74
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis 73
Undifferentiated connective tissue disease: the diagnoses critically revised-experience of a single center 72
Association of Natural Killer Cell Ligand Polymorphism, HLAC Asn80Lys, with the Development of Anti-SSA/Ro Associated Congenital Heart Block 70
Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers 70
Early echocardiographic alterations in SSc with anti-RNA polymerase III antibodies 70
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 69
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS) 68
Intrauterine fetal deaths related to antiphospholipid syndrome: a descriptive study of 65 women 67
Systemic lupus erythematosus: state of the art on clinical practice guidelines 66
Editorial: Into the heart of systemic autoimmune diseases. 63
Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational study 60
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study 60
Tapering belimumab in patients with systemic lupus erythematosus: a single-centre experience 60
Rare clinical manifestations in systemic lupus erythematosus: a review on frequency and clinical presentation 59
Totale 12.533
Categoria #
all - tutte 67.079
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.079


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021379 0 0 0 0 0 0 0 0 0 185 95 99
2021/2022776 67 83 54 41 12 54 26 60 44 95 71 169
2022/2023752 102 7 9 43 74 208 11 90 126 7 35 40
2023/2024927 55 21 79 114 58 151 37 49 198 26 20 119
2024/20252.702 23 38 40 238 195 186 144 92 222 209 579 736
2025/20264.374 402 618 325 672 470 322 685 174 253 453 0 0
Totale 13.588